A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

Veterans who were simultaneously prescribed opioids and benzodiazepines by the Veterans Health Administration (VHA) faced an ...

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms ...

Generally regarded as antidepressants ... to SSRIs is believed to be due to the placebo effect. How do anti-anxiety drugs work? There is no one pathway or mechanism by which anti-anxiety drugs ...

While there are many treatment options for depression, natural remedies, self-care methods, and alternative therapies can ...

People with lupus are at an increased risk of depression. Lupus is a chronic condition with recurring symptoms that can ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

While multiple drugs have been developed to ... activate DOP), such as SNC80 and KNT-127, exert antidepressant and anxiolytic effects (anti-anxiety) in animal models. However, the precise ...